Literature DB >> 3968741

Prognostic features in infants with obstructive uropathy due to posterior urethral valves.

B L Warshaw, L C Hymes, T S Trulock, J R Woodard.   

Abstract

The histories of 22 infants presenting during the first year of life with obstructive uropathy due to posterior urethral valves were analyzed to determine outcome and prognostic features. Mean patient age at the time of the initial surgical intervention was 39 days, and the mean duration of followup inclusive of renal function data was 5.8 years. One patient died (5 per cent) and one had end stage renal disease. The mean preoperative and postoperative serum creatinine concentrations during the initial hospitalization were 3.1 and 1.4 mg. per dl., respectively. Neither value was significantly predictive of the creatinine concentration at final followup. In contrast, the nadir creatinine value during the first year of life correlated significantly with final renal function. Children with nadir creatinine values less than or equal to 0.8 mg. per dl. by 12 months of age maintained creatinine levels less than or equal to 1.1 mg. per dl. at the time of final evaluation, whereas children with higher values during the first year of life were likely to have progressive renal failure. Of 19 final creatinine determinations 6 were normal and 5 exceeded 1.5 mg. per dl. Proteinuria, hypertension, renal biopsy findings, urinary infection, unilateral nephrectomy and type of surgery did not correlate significantly with functional outcome. Followup studies of longer duration are needed to determine the ultimate outcome of these patients, more than half of whom had some degree of renal insufficiency at final evaluation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968741     DOI: 10.1016/s0022-5347(17)48899-9

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  17 in total

Review 1.  Initial and long-term management of posterior urethral valves.

Authors:  P López Pereira; M J Martinez Urrutia; E Jaureguizar
Journal:  World J Urol       Date:  2004-11-19       Impact factor: 4.226

2.  Congenital posterior urethral obstruction: the historical perspective.

Authors:  P A Dewan
Journal:  Pediatr Surg Int       Date:  1997-02       Impact factor: 1.827

3.  Evolution of upper urinary tract and renal function in patients with posterior urethral valves.

Authors:  G Belloli; F Battaglino; A Mercurella; L Musi; D D'Agostino
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

4.  Posterior urethral valves: long-term outcome.

Authors:  Paolo Caione; Simona Gerocarni Nappo
Journal:  Pediatr Surg Int       Date:  2011-07-12       Impact factor: 1.827

5.  Renal parenchymal area and risk of ESRD in boys with posterior urethral valves.

Authors:  Jose E Pulido; Susan L Furth; Stephen A Zderic; Douglas A Canning; Gregory E Tasian
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-05       Impact factor: 8.237

Review 6.  Renal development in the fetus and premature infant.

Authors:  Stacy Rosenblum; Abhijeet Pal; Kimberly Reidy
Journal:  Semin Fetal Neonatal Med       Date:  2017-02-01       Impact factor: 3.926

7.  Posterior urethral valve in fetuses: evidence for the role of inflammatory molecules.

Authors:  Érica Leandro Marciano Vieira; Natalia Pessoa Rocha; Fernando Macedo Bastos; Kátia Daniela da Silveira; Alamanda K Pereira; Eduardo Araújo Oliveira; Débora Marques de Miranda; Ana Cristina Simões E Silva
Journal:  Pediatr Nephrol       Date:  2017-02-22       Impact factor: 3.714

8.  Prognostic factors of posterior urethral valves and the role of antenatal detection.

Authors:  Elisa Ylinen; Marja Ala-Houhala; Sakari Wikström
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

Review 9.  Neonatal obstructive uropathy.

Authors:  R H McLean; J P Gearhart; R Jeffs
Journal:  Pediatr Nephrol       Date:  1988-01       Impact factor: 3.714

Review 10.  Current strategies to predict and manage sequelae of posterior urethral valves in children.

Authors:  Aniruddh V Deshpande
Journal:  Pediatr Nephrol       Date:  2017-11-20       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.